Removal of Bile Acids by Two Different Extracorporeal Liver Support Systems in Acute-on-Chronic Liver Failure

No abstract is available for this paper.

• Publication year

  2007

• Venue

  ASAIO journal (1992)

• Publication date

  2007-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/01.mat.0000249852.71634.6cPMID 17413559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

  2008cited by this paper
• Removal selectivity of Prometheus: a new extracorporeal liver support device.

  2006cited by this paper
• Detoxifying Capacity and Kinetics of Prometheus® – A New Extracorporeal System for the Treatment of Liver Failure

  2005cited by this paper
• The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.

  2005cited by this paper
• Cytokine regulation of human sterol 12alpha-hydroxylase (CYP8B1) gene.

  2005cited by this paper
• In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.

  2005cited by this paper
• Human Hepatic Mitochondria Generate Reactive Oxygen Species and Undergo the Permeability Transition in Response to Hydrophobic Bile Acids

  2005cited by this paper
• Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene

  2005cited by this paper
• Quality of life in patients with primary biliary cirrhosis

  2004cited by this paper
• Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis

  2004cited by this paper
• Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.

  2004cited by this paper
• Extracorporeal Albumin Dialysis in a Patient with Primary Sclerosing Cholangitis: Effect on Pruritus and Bile Acid Profile

  2004cited by this paper
• Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis

  2004cited by this paper
• Baseline SOFA score and its lack of early improvement accurately predicts mortality in patients with acute-on-chronic liver failure.

  2004cited by this paper
• Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System

  2003cited by this paper
• Prometheus--a new extracorporeal system for the treatment of liver failure.

  2003cited by this paper
• Bound Solute Dialysis

  2003cited by this paper
• The pathophysiological basis of acute-on-chronic liver failure.

  2002cited by this paper
• Cholestatic liver disease: pathophysiology and therapeutic options.

  2002cited by this paper
• The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers.

  2002cited by this paper
• Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options

  2002cited by this paper
• Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study

  2002cited by this paper
• Bile acid‐induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition

  2001cited by this paper
• A model to predict survival in patients with end‐stage liver disease

  2001cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

  1999cited by this paper
• Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

  1999cited by this paper
• Bile Acids: The Good, the Bad, and the Ugly.

  1999cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996cited by this paper
• Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria

  1994cited by this paper
• Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease

  1992cited by this paper
• Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients.

  1991cited by this paper
• Potential bile acid precursors in plasma--possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man.

  1990cited by this paper
• Prognostic significance of serum bile acids in cirrhosis

  1986cited by this paper
• The patterns of glycine and taurine conjugates of bile acids in serum in hepatobiliary disease.

  1982cited by this paper
• Quantitative aspects of the interaction of bile acids with human serum albumin.

  1982cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

  1969cited by this paper

• Albumin dialysis modeling predicts the impact of polysulfone dialyzers and flow rate on cholic acid and indoxyl sulfate removal.

  2026cites this paper
• Safety and efficacy of Single-Pass Albumin Dialysis (SPAD), Prometheus, and Molecular Adsorbent Recycling System (MARS) liver haemodialysis vs. Standard Medical Therapy (SMT): meta-analysis and systematic review

  2024cites this paper
• Comparative metabolome analysis reveals higher potential of haemoperfusion adsorption in providing favourable outcome in ACLF patients

  2024cites this paper
• Extracorporeal liver support and liver transplantation for acute‐on‐chronic liver failure

  2023cites this paper
• Liver-Support Therapies in Critical Illness—A Comparative Analysis of Procedural Characteristics and Safety

  2023cites this paper
• Extracorporeal liver support techniques: a comparison

  2023cites this paper
• Superior Dialytic Removal of Bilirubin and Bile Acids by Free Fatty Acid Displacement and Its Synergy With Albumin-Based Dialysis

  2022cites this paper
• Therapeutic plasma exchange in liver failure

  2021cites this paper
• Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis

  2021cites this paper
• MARS: Should I Use It?

  2021cites this paper
• Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure—A retrospective analysis

  2020cites this paper
• Successful treatment of a patient with benign recurrent intrahepatic cholestasis type 1 with albumin dialysis.

  2020cites this paper
• Bile acid kinetic modeling in end-stage liver support patients

  2020cites this paper
• Acute-on-Chronic Liver Failure: Diagnosis, Prognosis, and Treatment

  2019cites this paper
• Effectiveness of extracorporeal hemocorrection methods in intensive therapy of liver failure

  2019cites this paper
• Extracorporeal Liver Support Devices

  2019cites this paper
• An evaluation of the usefulness of extracorporeal liver support techniques in patients with severe liver dysfunction

  2017influential citation
• Sensitivity Analysis of Two-Compartment Model Parameters for Extracorporeal Liver Therapy Purposes

  2017cites this paper
• Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery

  2017cites this paper
• Extracorporeal liver support devices for listed patients

  2016cites this paper
• Peritoneal Albumin Dialysis as a Novel Approach for Liver Support: Study in a Porcine Model of Acute Hepatic Failure.

  2016cites this paper
• Artificial Liver Treatment, When and Which One?

  2016cites this paper
• Liver depurative techniques: a single liver transplantation center experience.

  2015cites this paper
• Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study

  2015cites this paper
• Extracorporeal Treatments for Poisoning : Overview and Limitations

  2014cites this paper
• Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.

  2014cites this paper
• Available Extracorporeal Treatments for Poisoning: Overview and Limitations

  2014cites this paper
• Development of high-efficiency molecular adsorbent recirculating system: preliminary report.

  2014cites this paper
• Diagnostik und Behandlung des akuten Leberversagens

  2014cites this paper
• Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation

  2014cites this paper
• Activated carbon & carbon-cryogel composites for haemoperfusion based applications

  2013cites this paper
• Sistemas no biológicos de soporte hepático artificial: ¿En qué consisten y qué rol ocupan en la actualidad?

  2012cites this paper
• The challenge of cholestatic pruritus.

  2012cites this paper
• Long-Term Therapy of a Patient with Summerskill-Walshe-Tygstrup Syndrome by Applying Prometheus® Liver Dialysis: A Case Report

  2012cites this paper
• Clearing of toxic substances: are there differences between the available liver support devices?

  2011cites this paper
• Cerebral metabolism during acute liver failure and the effect of treatment with fractionated plasma separation and

  2011cites this paper
• [Artificial liver support. Literature review].

  2011cites this paper
• Extracorporeal Artificial Liver Support Systems

  2011cites this paper
• Sistemas de soporte heptico artificial. Revisin de la bibliografa mdica

  2011cites this paper
• Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).

  2011cites this paper
• Acute-on-chronic liver failure: extracorporeal liver assist devices

  2011cites this paper
• MARS and Prometheus in Acute-on-Chronic Liver Failure: Toxin Elimination and Outcome

  2010cites this paper
• A CRITICAL EVALUATION OF THE MARS TREATMENT IN FINLAND

  2010cites this paper
• [Evaluation of extracorporeal liver support systems in the treatment of liver failure. A systematic review].

  2010cites this paper
• Evaluación de los sistemas de soporte hepático extracorpóreo en el tratamiento de la insuficiencia hepática. Revisión sistemática

  2010influential citation
• Effect of Extracorporeal Liver Support by Molecular Adsorbents Recirculating System and Prometheus on Redox State of Albumin in Acute‐on‐Chronic Liver Failure

  2009cites this paper
• Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation

  2009cites this paper
• What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation.

  2009cites this paper
• Mars and Prometheus: our clinical experience in acute chronic liver failure.

  2008cites this paper
• Liver support devices

  2008cites this paper
• Artificial Liver Support Systems in the Management of Complications of Cirrhosis

  2008influential citation
• Innovative Strategien zur Therapie des Leberversagens - artifizielle, bioartifizielle und biologische Leberunterstützungskonzepte

  2008cites this paper
• Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.

  2008cites this paper
• The future of extracorporeal support

  2008cites this paper
• Acute liver failure: liver support therapies

  2007cites this paper
• Albumin dialysis: an update

  2007cites this paper
• Extracorporal blood purification: more than diffusion and convection. Does this help?

  2007cites this paper
• Technology Insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®?

  2007cites this paper
• Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure

  2006cites this paper